Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV

Overview

These guidelines provide guidance on the diagnosis of human immunodeficiency virus (HIV) infection, the use of antiretroviral (ARV) drugs for treating and preventing HIV infection and the care of people living with HIV. They are structured along the continuum of HIV testing, prevention, treatment and care.

This edition updates the 2013 consolidated guidelines on the use of antiretroviral drugs following an extensive review of evidence and consultations in mid-2015, shared at the end of 2015, and now published in full in 2016. It is being published in a changing global context for HIV and for health more broadly.

Foreword by Dr Margaret Chan, Director-General, WHO
The guidelines by chapter

Executive summary
pdf, 49kb
Summary of recommendations
pdf, 118kb
Chapter 1 - Introduction
pdf, 127kb
Chapter 2 - Clinical guidelines: HIV diagnosis
pdf, 204kb
Chapter 3 - Clinical guidelines: antiretroviral drugs for HIV prevention
pdf, 148kb
Chapter 4 - Clinical guidelines: antiretroviral therapy
pdf, 486kb
Chapter 5 - Clinical guidelines: managing common coinfections and comorbidities
pdf, 276kb
Chapter 6 - Service delivery
pdf, 809kb
Chapter 7 - Monitoring and evaluation
pdf, 210kb
Chapter 8 - Publication, dissemination and evaluation
pdf, 68kb
Annexes
pdf, 2.04Mb
Related links

Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV
September 2015
Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: what’s new
Policy brief - November 2015
More about treatment and care
HIV guidelines
HIV policy briefs